Reilly Financial Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Reilly Financial Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$8K	Hold	150	–	–	﹤0.01%	747
2021 Q3	$9K	Hold	150	–	–	﹤0.01%	672
2021 Q2	$12K	Hold	150	–	–	﹤0.01%	658
2021 Q1	$12K	Hold	150	–	–	﹤0.01%	653
2020 Q4	$11K	Hold	150	–	–	﹤0.01%	604
2020 Q3	$16K	Hold	150	–	–	﹤0.01%	478
2020 Q2	$23K	Hold	150	–	–	﹤0.01%	420
2020 Q1	$12K	Hold	150	–	–	﹤0.01%	515
2019 Q4	$25K	Hold	150	–	–	﹤0.01%	453
2019 Q3	$28K	Hold	150	–	–	﹤0.01%	442
2019 Q2	$34K	Hold	150	–	–	﹤0.01%	425
2019 Q1	$32K	Buy	+150	New	+$28.1K	﹤0.01%	425
2018 Q4	–	Sell	-150	Closed	-$34K	–	936
2018 Q3	$34K	Buy	150 +50	+50%	+$11.1K	﹤0.01%	428
2018 Q2	$22K	Hold	100	–	–	﹤0.01%	468
2018 Q1	$23K	Hold	100	–	–	﹤0.01%	447
2017 Q4	$26K	Hold	100	–	–	﹤0.01%	440
2017 Q3	$22K	Buy	+100	New	+$24.6K	﹤0.01%	469

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Reilly Financial Advisors's AXDX Position: Q4 2021 in Review

Reilly Financial Advisors held its Accelerate Diagnostics (AXDX) position steady in Q4 2021 at 150 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Reilly Financial Advisors first reported a position in AXDX in Q3 2017 and has held it in 17 quarters since. The position peaked at $34K in Q2 2019. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

Reilly Financial Advisors held 150 shares of Accelerate Diagnostics worth $8K as of Q4 2021.
Reilly Financial Advisors left its Accelerate Diagnostics share count unchanged in Q4 2021.
Accelerate Diagnostics made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #747 holding.
Reilly Financial Advisors first reported a position in Accelerate Diagnostics in Q3 2017 and has held it in 17 quarters since.
Reilly Financial Advisors's Accelerate Diagnostics position peaked at $34K in Q2 2019.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.